Benjamin Movsas MD FASTRO, FACR, FARS
Medical Director, Henry Ford Health-Cancer Chair, Dept of Radiation Oncology
Join to View Full Profile
Henry Ford Health System2799 West Grand BoulevardDetroit, MI 48202
Phone+1 313-916-9106
Fax+1 313-916-1249
Dr. Movsas is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
National Capital ConsortiumResidency, Radiation Oncology, 1992 - 1995
Johns Hopkins UniversityResidency, Radiology-Diagnostic, 1991 - 1992
Sinai Hospital of BaltimoreInternship, Internal Medicine, 1990 - 1991
WashU MedicineClass of 1990
HarvardBa, Biochemistry , Magna cum lauds
Certifications & Licensure
MI State Medical License 2004 - 2027
NJ State Medical License 1997 - 2005
PA State Medical License 1995 - 2004
MD State Medical License 1992 - 1995
American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013, 2015-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2013, 2015-2017
- CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2013, 2015-2017
Clinical Trials
- Amifostine in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer Start of enrollment: 1998 Sep 01
- Vaccine Therapy Plus Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer That Has Been Completely Removed in Surgery Start of enrollment: 2001 Mar 01
- Randomized Trial of Suicide Gene Therapy and Prostate Cancer Start of enrollment: 2007 Dec 01
Publications & Presentations
PubMed
- Quality of life results of addition of androgen deprivation therapy and pelvic lymph node treatment to prostate bed salvage radiotherapy: NRG Oncology/RTOG 0534 SPPORT.Deborah W Bruner, Theodore G Karrison, Alan Pollack, Jeff M Michalski, Alexander G Balogh
International Journal of Radiation Oncology, Biology, Physics. 2026-07-14 - Concurrent Versus Sequential Radiation Dose Escalation to the Surgical Cavity for Conservative Treatment of High-Risk Early Breast Cancer: NRG/RTOG 1005 Phase III Trial.Frank A Vicini, Kathryn Winter, Gary M Freedman, Douglas W Arthur, Barry S Rosenstein
Journal of Clinical Oncology. 2026-07-01 - AKT, ATR, and Notch Inhibitors Radiosensitize a Preclinical Model of Adenoid Cystic Carcinoma.Shivani Thoidingjam, Sushmitha Sriramulu, Asya Haider Muratoglu, Stephen Brown, Oudai Hassan
Head & Neck. 2026-04-01
Journal Articles
- Principal Component Analysis (PCA) Modeling of Head‐and‐Neck Anatomy Using Daily CBCT ImagesBenjamin Movsas, MD, Medical Physics
- Influence of Residual Disease Following Surgical Resection in Newly Diagnosed Glioblastoma on Clinical, Neurocognitive, and Patient Reported OutcomesKevin S Roof, Paul D Brown, Samuel T Chao, William A Hall, Minesh P Mehta, Benjamin Movsas, Jeffrey S Wefel, Neurosurgery
Authored Content
- Radiation Therapy in Elderly Persons: An Old Issue with New ApproachesJuly 2017
Press Mentions
Immunotherapy Addition Yields QOL Benefits in Limited-Stage Small Cell Lung CancerOctober 6th, 2025- Patient-Reported Outcomes from NRG Oncology Trial Indicate Quality of Life Improvement with Twice-Daily vs. Once-Daily Radiation in Limited-Stage Small Cell Lung CancerSeptember 30th, 2025
- Patient-Reported Outcome Analysis of NRG Oncology Trial in Limited-Stage Small Cell Lung Cancer Suggests Quality of Life Benefit with Twice - (vs Once -) Daily RadiationSeptember 30th, 2025
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
